Edurant indication extension for adolescents
The summary of product characteristics for Edurant (rilpivirine; Janssen-Cilag) now states that the drug can be taken by adolescents of 12 years and above, as well as adults.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200183
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com